Nearly 800,000 Pfizer shots arrive in PH | Inquirer News

Nearly 800,000 Pfizer shots arrive in PH

By: - Reporter / @DYGalvezINQ
/ 09:47 PM October 07, 2021

A total of 797,940 doses of US-made Pfizer COVID-19 vaccine arrived in the Philippines on Thursday night. 

FILE PHOTO: A vial labeled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration

MANILA, Philippines — A total of 797,940 doses of US-made Pfizer COVID-19 vaccine arrived in the Philippines on Thursday night.

The vaccine doses arrived at the Ninoy Aquino International Airport Terminal 3 at around 8:30 p.m., as shown on a livestream by state-run PTV.

Article continues after this advertisement

The National Task Force against COVID-19 said 64,350 doses will be delivered to Davao on Friday morning.

Vaccine czar Carlito Galvez Jr. earlier said the country’s COVID-19 vaccine supply may reach over 100 million doses by the end of October.

JPV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Delivery, Pfizer, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.